PULMONX CORPORATION (LUNG) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $43.00K; Additional Paid in Capital, Common StockUSD $582.40M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.05M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $42.00K; Additional Paid in Capital, Common StockUSD $578.76M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.17M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $42.00K; Additional Paid in Capital, Common StockUSD $573.27M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.36M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in Capital, Common StockUSD $568.89M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.24M.
PULMONX CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $43.00K | $582.40M | $2.05M | $-545.29M | $39.20M | 3 month · $3.63M | (m) | (m) |
| 2026-03-31 | $0.00 | $42.00K | $578.76M | $2.17M | $-535.21M | $45.76M | 3 month · $4.14M | 3 month · $1.10M | (m) |
| 2025-12-31 | $0.00 | $42.00K | $573.27M | $2.36M | $-521.56M | $54.12M | 12 month · $21.06M | (m) | (m) |
| 2025-09-30 | $0.00 | $41.00K | $568.89M | $2.24M | $-511.13M | $60.03M | 3 month · $5.09M | (m) | (m) |
| 2025-06-30 | $0.00 | $41.00K | $563.59M | $2.64M | $-497.18M | $69.09M | 3 month · $6.13M | (m) | (m) |
| 2025-03-31 | $0.00 | $40.00K | $557.43M | $2.20M | $-482.00M | $77.67M | 3 month · $5.55M | (m) | (m) |
| 2024-12-31 | $0.00 | $40.00K | $551.21M | $2.11M | $-467.56M | $85.81M | 12 month · $22.96M | (m) | (m) |
| 2024-09-30 | $0.00 | $39.00K | $545.73M | $2.53M | $-454.38M | $93.92M | 3 month · $5.86M | (m) | (m) |
| 2024-06-30 | $0.00 | $39.00K | $539.41M | $1.97M | $-440.24M | $101.18M | 3 month · $5.98M | (m) | (m) |
| 2024-03-31 | $0.00 | $39.00K | $533.41M | $1.96M | $-424.91M | $110.50M | 3 month · $5.74M | (m) | (m) |
| 2023-12-31 | $0.00 | $39.00K | $526.80M | $2.64M | $-411.16M | $118.31M | 12 month · $22.44M | (m) | (m) |
| 2023-09-30 | $0.00 | $38.00K | $521.03M | $1.94M | $-397.27M | $125.74M | 3 month · $6.10M | (m) | (m) |
| 2023-06-30 | $0.00 | $38.00K | $514.33M | $1.96M | $-382.37M | $133.95M | 3 month · $5.89M | (m) | (m) |
| 2023-03-31 | $0.00 | $38.00K | $508.25M | $1.82M | $-366.18M | $143.93M | 3 month · $4.76M | (m) | (m) |
| 2022-12-31 | $0.00 | $38.00K | $502.71M | $1.57M | $-350.32M | $154.01M | 12 month · $17.02M | (m) | (m) |
| 2022-09-30 | $0.00 | $37.00K | $498.08M | $1.40M | $-336.04M | $163.48M | 3 month · $4.47M | (m) | (m) |
| 2022-06-30 | $0.00 | $37.00K | $492.65M | $1.36M | $-321.86M | $172.18M | 3 month · $4.55M | (m) | (m) |
| 2022-03-31 | $0.00 | $37.00K | $487.89M | $1.44M | $-307.22M | $182.15M | 3 month · $3.62M | (m) | (m) |
| 2021-12-31 | $0.00 | $37.00K | $482.88M | $1.71M | $-291.39M | $193.24M | 12 month · $11.00M | (m) | (m) |
| 2021-09-30 | $0.00 | $37.00K | $479.64M | $1.54M | $-278.39M | $202.83M | 3 month · $3.04M | (m) | (m) |
| 2021-06-30 | $0.00 | $36.00K | $475.56M | $1.48M | $-268.21M | $208.87M | 3 month · $2.48M | (m) | (m) |
| 2021-03-31 | $0.00 | $36.00K | $469.95M | $1.41M | $-255.25M | $216.15M | 3 month · $2.46M | (m) | (m) |
| 2020-12-31 | $0.00 | $36.00K | $467.15M | $1.69M | $-242.73M | $226.13M | 12 month · $3.49M | (m) | (m) |
| 2020-09-30 | (m) | $4.00K | $24.90M | $1.65M | $-233.44M | $-206.89M | 3 month · $518.00K | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-205.76M | 3 month · $159.00K | (m) | (m) |
| 2020-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $1.80M |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-194.04M | 3 month · $209.00K | (m) | (m) |
| 2019-12-31 | $0.00 | $2.00K | $21.75M | $1.37M | $-210.50M | $-187.38M | 12 month · $364.00K | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $-182.84M | 3 month · $72.00K | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-178.79M | 3 month · $75.00K | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $-173.41M | 3 month · $50.00K | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-167.33M | 12 month · $366.00K | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $-149.39M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |